IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30

Immuron Ltd

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 24, 2026

$0.96−0.03 (-2.62%)

Close on Oct 19, 2026

Immuron Ltd balance sheet

Annual Quarterly

AUD USD

Millions of USD, except per-share data. Shares in millions.

Line item	Q4 2026 2026-06-30	Q4 2025 2025-06-30	Q4 2024 2024-06-30	Q4 2023 2023-06-30	Q4 2022 2022-06-30	Q4 2021 2021-06-30	Q4 2020 2020-06-30	Q4 2019 2019-06-30	Q4 2018 2018-06-30	Q4 2017 2017-06-30	Q4 2016 2016-06-30	Q4 2015 2015-06-30
Cash & Equivalents	6.24	1.86	7.78	11	15	19	2.24	3.59	3.50	3.07	1.70	2.40
Cash & Short-Term Investments	6.24	1.86	7.78	11	15	19	2.24	3.59	3.50	3.07	1.70	2.40
Receivables	0.97	1.27	0.93	0.28	0.46	0.25	0.23	0.68	1.25	1.36	–	–
Inventory	1.57	1.16	1.06	0.56	0.23	0.22	0.55	0.38	0.37	1.79	–	–
Other Current Assets	0.18	2.29	0.06	0.11	0.40	0.06	0.02	0.03	0.10	0.13	–	–
Total Current Assets	8.96	6.58	9.83	14	16	19	3.04	4.68	5.22	6.35	–	–
Property, Plant & Equipment	0.01	0.01	0.10	0.13	0.16	0.03	0.05	0.01	0.02	0.01	–	–
Operating Lease Right-of-Use Assets	0.13	0.07	0.09	0.12	0.14	0.01	0.04	0.07	–	–	–	–
Deferred Tax Assets	–	–	–	0.02	0.01	–	–	–	7.18	6.36	–	–
Total Assets	9.09	6.66	10	15	17	20	4.28	6.00	6.84	6.36	6.56	–
Accounts Payable	0.93	1.01	1.43	0.79	0.80	0.57	0.26	0.77	0.51	0.99	–	–
Short-Term Debt	–	–	–	–	–	–	–	–	–	0.11	–	–
Current Debt	–	–	–	–	–	–	–	–	–	0.11	–	–
Current Portion of Leases	–	–	0.03	0.03	0.02	0.02	0.03	–	–	–	–	–
Current Income Taxes Payable	–	–	–	0.47	–	–	–	–	–	–	–	–
Other Current Liabilities	0.02	0.03	0.03	0.03	0.02	0.02	0.03	–	–	–	–	–
Total Current Liabilities	1.23	1.29	1.80	1.48	1.04	0.84	0.36	0.84	0.59	1.31	–	–
Long-Term Leases	–	–	0.09	0.10	0.12	–	0.01	–	–	–	–	–
Operating Lease Liabilities	–	–	0.12	0.13	0.14	0.02	0.04	0.07	–	–	–	–
Deferred Tax Liabilities	–	–	–	–	0.14	–	–	–	–	–	–	–
Other Long-Term Liabilities	0.11	0.05	0.09	0.10	0.12	–	0.01	–	–	–	–	–
Total Liabilities	1.37	1.35	1.90	1.58	1.16	0.87	0.38	0.85	0.59	1.31	2.89	–
Total Debt	–	–	–	–	–	–	–	–	–	0.11	–	–
Common Stock	66	58	59	59	61	66	43	42	43	41	–	–
Additional Paid-In Capital	0.00	–	–	–	–	–	–	–	–	–	–	–
Retained Earnings	-59	-54	-53	-48	-47	-49	-40	-40	-39	-38	–	–
Total Equity	7.72	5.30	8.49	13	16	19	3.89	5.15	6.24	5.05	–	–
Shares Outstanding(shares)	–	–	–	0.00	–	–	–	–	130	80	75	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2026

Gross margin: 64.5%
Operating margin: -49.9%
Net margin: -47.7%
Return on equity, FY2026: –

Financial strength

Current ratio: 7.26
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 505.1%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.